1. Home
  2. BCAB vs RSSS Comparison

BCAB vs RSSS Comparison

Compare BCAB & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • RSSS
  • Stock Information
  • Founded
  • BCAB 2007
  • RSSS 2006
  • Country
  • BCAB United States
  • RSSS United States
  • Employees
  • BCAB N/A
  • RSSS N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • RSSS Business Services
  • Sector
  • BCAB Health Care
  • RSSS Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • RSSS Nasdaq
  • Market Cap
  • BCAB 96.2M
  • RSSS 86.4M
  • IPO Year
  • BCAB 2020
  • RSSS N/A
  • Fundamental
  • Price
  • BCAB $2.08
  • RSSS $2.68
  • Analyst Decision
  • BCAB Strong Buy
  • RSSS Strong Buy
  • Analyst Count
  • BCAB 2
  • RSSS 1
  • Target Price
  • BCAB $6.00
  • RSSS $6.00
  • AVG Volume (30 Days)
  • BCAB 1.6M
  • RSSS 30.4K
  • Earning Date
  • BCAB 11-08-2024
  • RSSS 11-07-2024
  • Dividend Yield
  • BCAB N/A
  • RSSS N/A
  • EPS Growth
  • BCAB N/A
  • RSSS N/A
  • EPS
  • BCAB N/A
  • RSSS N/A
  • Revenue
  • BCAB N/A
  • RSSS $44,623,899.00
  • Revenue This Year
  • BCAB N/A
  • RSSS $13.76
  • Revenue Next Year
  • BCAB N/A
  • RSSS $9.92
  • P/E Ratio
  • BCAB N/A
  • RSSS N/A
  • Revenue Growth
  • BCAB N/A
  • RSSS 18.35
  • 52 Week Low
  • BCAB $1.14
  • RSSS $2.21
  • 52 Week High
  • BCAB $4.02
  • RSSS $3.50
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 55.80
  • RSSS 50.43
  • Support Level
  • BCAB $1.87
  • RSSS $2.55
  • Resistance Level
  • BCAB $2.13
  • RSSS $2.75
  • Average True Range (ATR)
  • BCAB 0.12
  • RSSS 0.10
  • MACD
  • BCAB 0.00
  • RSSS -0.00
  • Stochastic Oscillator
  • BCAB 68.90
  • RSSS 53.57

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About RSSS Research Solutions Inc

Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.

Share on Social Networks: